X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761112
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761112
http://www.pharmatimes.com/news/nice_green_light_for_cablivi_in_rare_blood-clotting_disorder_1356888
http://www.pharmatimes.com/news/nice_rejects_sanofis_cablivi_in_draft_guidelines_1342109
https://www.newswire.ca/news-releases/cablivi-r-caplacizumab-approved-by-health-canada-for-adults-living-with-acquired-thrombotic-thrombocytopenic-purpura-attp--808888426.html
http://www.news.sanofi.us/2019-10-09-Innovative-treatment-Cablivi-caplacizumab-yhdp-granted-new-technology-payment-NTAP-for-Medicare-payment
https://www.fiercebiotech.com/biotech/zeldin-joins-immunovant-as-cmo-months-after-acceleron-split
https://www.reuters.com/article/us-sanofi-fr-fda/sanofi-blood-disorder-drug-wins-fda-approval-idUSKCN1PV22V
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761112
https://www.prnewswire.com/news-releases/fda-approves-first-therapy-for-the-treatment-of-adult-patients-with-a-rare-blood-clotting-disorder-300790948.html
http://www.pharmatimes.com/news/cablivi_gets_positive_results_for_rare_blood_clotting_disorder_1274525
https://globenewswire.com/news-release/2019/01/09/1685866/0/en/New-England-Journal-of-Medicine-publishes-positive-results-of-the-pivotal-trial-of-Cablivi-caplacizumab-for-rare-blood-clotting-disorder.html
https://endpts.com/with-radiotherapy-en-vogue-belgian-startup-nabs-nearly-42m-in-series-a-funding/
https://www.ema.europa.eu/documents/product-information/cablivi-epar-product-information_en.pdf
Market Place
Share 
